Stay updated on Dulaglutide Efficacy & Safety in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Dulaglutide Efficacy & Safety in Type 2 Diabetes Clinical Trial page.

Latest updates to the Dulaglutide Efficacy & Safety in Type 2 Diabetes Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.0%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study information regarding the efficacy and safety of investigational dulaglutide doses for type 2 diabetes, and the addition of a new identifier related to Eli Lilly and Company.SummaryDifference11%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
- Check66 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.8%
- Check87 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.8%
Stay in the know with updates to Dulaglutide Efficacy & Safety in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dulaglutide Efficacy & Safety in Type 2 Diabetes Clinical Trial page.